An in silico -in vitro pipeline identifying an HLA-A*02:01+ KRAS G12V+ spliced epitope candidate for a broad tumor-immune response in cancer patients

Recommended citation: Mishto, M.,Mansurkhodzhaev, A.,Ying, G.,Bitra, A.,Cordfunke, A R.,Henze, S., Paul, D.,Sidney, J.,Urlaub, H.,Neefjes, J., Sette, A.,Dirk, Z.,Liepe, J., 2019. An in silico-in vitro pipeline identifying an HLA-A*02:01+ KRAS G12V+spliced epitope candidate for a broad tumor-immune response in cancer patients. Frontiers in Immunology. Accepted for publication.